Nivolumab for metastatic renal cell carcinoma: Results of a randomized phase II trial.
Journal of Clinical Oncology.
Times cited: 551
Exercise as treatment for androgen deprivation therapy-associated physical dysfunction: Ready for prime time?.
Times cited: 8